Logos Global Management LP 13D and 13G filings for Eledon Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-26 4:27 pm Sale |
2022-01-20 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Logos Global Management LP | 0 0.000% |
-1,339,793 (Position Closed) |
Filing |
| 2021-09-09 12:30 pm Purchase |
2020-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Logos Global Management LP | 1,339,793 9.400% |
1,339,793 (New Position) |
Filing |